CORD-19:c654596857bce9cdd64ffc51842048643107348c / 483716-483973 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T4137","span":{"begin":0,"end":257},"obj":"Sentence"},{"id":"T34908","span":{"begin":0,"end":257},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The pharmacology of an intravenous once-daily dose (OD) of 400 mg MOX was determined with five gram-negative and -positive pathogens (Streptococcus pyogenes , Streptococcus pneumoniae , Moraxella catarrhalis , Escherichia coli , and Klebsiella pneumoniae )."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T309","span":{"begin":0,"end":257},"obj":"Sentence"}],"text":"The pharmacology of an intravenous once-daily dose (OD) of 400 mg MOX was determined with five gram-negative and -positive pathogens (Streptococcus pyogenes , Streptococcus pneumoniae , Moraxella catarrhalis , Escherichia coli , and Klebsiella pneumoniae )."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T878","span":{"begin":173,"end":183},"obj":"Phenotype"},{"id":"T879","span":{"begin":244,"end":254},"obj":"Phenotype"}],"attributes":[{"id":"A878","pred":"hp_id","subj":"T878","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A879","pred":"hp_id","subj":"T879","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"The pharmacology of an intravenous once-daily dose (OD) of 400 mg MOX was determined with five gram-negative and -positive pathogens (Streptococcus pyogenes , Streptococcus pneumoniae , Moraxella catarrhalis , Escherichia coli , and Klebsiella pneumoniae )."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2190","span":{"begin":52,"end":54},"obj":"Disease"},{"id":"T2191","span":{"begin":159,"end":183},"obj":"Disease"},{"id":"T2192","span":{"begin":233,"end":254},"obj":"Disease"},{"id":"T5611","span":{"begin":52,"end":54},"obj":"Disease"},{"id":"T85044","span":{"begin":159,"end":183},"obj":"Disease"},{"id":"T28566","span":{"begin":233,"end":254},"obj":"Disease"}],"attributes":[{"id":"A2190","pred":"mondo_id","subj":"T2190","obj":"http://purl.obolibrary.org/obo/MONDO_0017178"},{"id":"A2191","pred":"mondo_id","subj":"T2191","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A2192","pred":"mondo_id","subj":"T2192","obj":"http://purl.obolibrary.org/obo/MONDO_0030602"},{"id":"A5654","pred":"mondo_id","subj":"T5611","obj":"http://purl.obolibrary.org/obo/MONDO_0017178"},{"id":"A4266","pred":"mondo_id","subj":"T85044","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A27482","pred":"mondo_id","subj":"T28566","obj":"http://purl.obolibrary.org/obo/MONDO_0030602"}],"text":"The pharmacology of an intravenous once-daily dose (OD) of 400 mg MOX was determined with five gram-negative and -positive pathogens (Streptococcus pyogenes , Streptococcus pneumoniae , Moraxella catarrhalis , Escherichia coli , and Klebsiella pneumoniae )."}